Medicine found "too expensive" in Switzerland

Prescription medication is far more expensive in Switzerland than it is in other countries, according to a study released on Wednesday.

This content was published on November 23, 2011 - 11:27 and agencies

Santésuisse, the association of Swiss health insurers, says that Swiss consumers pay SFr300 million ($327.4 million) too much each year.

In its study, Santésuisse compared the profit margins on prescription drugs in Switzerland to those in six other European countries: Austria, Britain, Denmark, France, Germany and the Netherlands.

It found that the profit margin was highest in Switzerland. Even when accounting for the higher salaries, rents and interest rates, Santésuisse reported that the Swiss margin was up to 45 per cent larger than in other nations.

The potential savings could amount to SFr300 million or 1.5 per cent in health insurance premiums. Santésuisse recommends that it be allowed to negotiate prices of prescription drugs directly with distribution partners.

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Change your password

Do you really want to delete your profile?